PASSERINE
DEAD

Serial Number

90546858

Owner

Passerine Therapeutics, Inc.

Attorney

Boris Umansky

Filing Date

Feb 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PASSERINE Trademark

Serial Number: 90546858

PASSERINE is a trademark filed by Passerine Therapeutics, Inc. on February 25, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Passerine Therapeutics, Inc.

100 Pine St. Ste #1250
San Francisco, CA 94111

Entity Type: 03

Trademark Details

Filing Date

February 25, 2021

Registration Date

Not Registered

Published for Opposition

November 2, 2021

Goods & Services

Allergy relief medication; pharmaceutical products for the treatment of viral diseases; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of immune system related diseases and disorders; antibiotics; pharmaceutical products for treating respiratory diseases; pharmaceutical preparations for treating asthma; pharmaceutical agents for epidermis; anesthetics for surgical use; cardiovascular pharmaceutical preparations; pharmaceutical products for the treatment of infectious diseases; pharmaceutical agents affecting sensory organs; antiallergic medicines; pharmaceutical preparations for peripheral nervous system; medicines for dental purposes; pharmaceutical agents affecting digestive organs; eye drops; ear drops; nasal sprays for medical purposes; medical preparation for slimming purposes; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; tumor suppressing agents; pain relief medication; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for treating hypertension; anaesthetics; alcohol for pharmaceutical purposes; diagnostic reagents for medical use; capsules sold empty for pharmaceuticals; dietetic preparations adapted for medical purposes; adhesive plasters for medical purposes; medical dressings; teeth filling material; lacteal flour for babies; nutritional supplements; baby food; dietary supplements for animals; semen for artificial insemination

Research in the field of pharmaceuticals; pharmaceutical product evaluation; conducting early evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; research on the subject of pharmaceuticals; drug discovery services; pharmaceutical research services; development of pharmaceutical preparations and medicines; medical research; chemical research; research in the field of chemistry; chemistry consultation; chemical analysis; bacteriological research; biological research; conducting clinical trials for others; scientific research; scientific laboratory services

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 1, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 1, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 28, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 27, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 24, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 24, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 24, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 24, 2021 CNEA
ASSIGNED TO EXAMINER
Sep 20, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2021 NWOS
NEW APPLICATION ENTERED
Mar 1, 2021 NWAP